Relmada Therapeutics, Inc. (RLMD) vs Zura Bio Limited (ZURA)

Relmada Therapeutics, Inc. and Zura Bio Limited are both Biotechnology companies. Relmada Therapeutics, Inc. and Zura Bio Limited are of similar size ($406.4M and $398.7M). Across the 8 metrics below, Relmada Therapeutics, Inc. leads on 6 and Zura Bio Limited on 2.

Valuation

Metric RLMD ZURA Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 2.08 2.60 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (23.50%) (27.97%) (28.84%)
Free cash flow yield (29.59%) (16.13%) (23.03%)

Profitability

Metric RLMD ZURA Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (55.66%) (71.76%) (57.72%)
Return on assets (51.57%) (62.74%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric RLMD ZURA Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 45.28% (76.67%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric RLMD ZURA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 29.52 12.90 4.73
Net debt to EBITDA 1.57 1.45 0.96

Dividend

Metric RLMD ZURA Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric RLMD ZURA Biotechnology median
Market cap 406.41m 398.65m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack